Insulin infusion amplifies 17α-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: Apparent relative impairment of 17,20-lyase activity

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 881-886

  Moghetti, Paolo ^a,d   Castello, Roberto ^a   Negri, Carlo ^a   Tosi, Flavia ^a   Spiazzi, Giovanna G ^a   Brun, Elisabetta ^a   Balducci, Rina ^b   Toscano, Vincenzo ^c   Muggeo, Michele ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYPREGNENOLONE; ANDROSTENEDIONE; CORTICOTROPIN; HYDROCORTISONE; HYDROXYCORTICOSTEROID; HYDROXYPROGESTERONE; INSULIN; ISOPHANE INSULIN; PRASTERONE; PROGESTERONE; STEROID 17,20 LYASE; TETRACOSACTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERANDROGENISM; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STEROIDOGENESIS;

17-ALPHA-HYDROXYPREGNENOLONE; 17-ALPHA-HYDROXYPROGESTERONE; 17-HYDROXYCORTICOSTEROIDS; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; DEHYDROEPIANDROSTERONE; FEMALE; HORMONES; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; INSULIN; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0029927833     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.3.881     Document Type: Article

References (46)

1. Poretsky L. 1991 On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev. 12:3-13.
2. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
3. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:356-359.
4. Shoupe D, Kumar DD, Lobo RA. 1983 Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol. 147:588-592.
5. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. 1986 Insulin stimulates androgen accumulations in incubation of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:904-910.
6. Poretsky L, Kalin MF. 1987 The gonadotropic function of insulin. Endocr Rev. 8:132-141.
7. Hernandez ER, Resnick CE, Holtzclaw WD, Payne DW, Adashi EY. 1988 Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular mechanism(s) underlying physiological and pharmacological hormonal actions. Endocrinology. 122:2034-2043.
8. Cara JF, Rosenfield RL. 1988 Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 123:733-739.
9. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. 1990 Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil Steril. 53:785-791.
10. Ehrmann DA, Barnes RB, Rosenfield RL. 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:322-369.
11. Miller WL. 1988 Molecular biology of steroid hormone synthesis. Endocr Rev. 9:295-318.
12. 5-steroid-17,20-lyase reactions. Mol Endocrinol. 3:968-975.
13. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenisms and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol. 167:1807-1812.
14. Azziz R, Bradley Jr EL, Potter HD, Boots LR. 1993 3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am J Obstet Gynecol. 168:889-895.
15. Lachelin GCL, Barnett M, Hopper BR, Brink G, Yen SSC. 1979 Adrenal function in normal women and women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 49:892-898.
16. Rodin A, Thakkar H, Taylor N, Clayton R. 1994 Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med. 330:460-465.
17. Gross MD, Wortsman J, Shapiro B, Meyers LC, Woodbury MC, Ayers JWT. 1986 Scintigraphic evidence of adrenal cortical dysfunction in the polycystic ovary syndrome. J Clin Endocrinol Metab. 62:197-201.
18. Hoffman DI, Klove K, Lobo RA. 1984 The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril. 42:76-81.
19. Wild RA, Umstot ES, Andersen RN, Ranney GB, Givens JR. 1983 Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol. 146:602-606.
20. Kirschner A, Jacobs JB. 1971 Combined ovarian and adrenal vein catheterization to determine the site(s) of androgen over-production in hirsute women. J Clin Endocrinol Metab. 33:199-209.
21. Hague WM, Honour JW, Adams J, Vecsei P, Jacobs HS. 1489 Steroid responses to ACTH in women with polycystic ovaries. Clin Endocrinol (Oxf). 30:355-365.
22. Moltz L, Schwartz U, Sorensen R, Pickartz H, Hammerstein J. 1984 Ovarian and adrenal vein steroids in patients with non-neoplastic hyperandrogenism: selective catheterization findings. Fertil Steril. 42:69-75.
23. Bianchi P, Toscano V, Monaco G, Marano G, Lubrano C, Sciarra F. 1993 Effects of ACTH, insulin and insulin-like growth factor-I on guinea pig adrenals fasciculata-glomerulosa cells [Abstract]. J Endocrinol Invest. 16(Suppl I):88.
24. Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S. 1992 Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. Fertil Steril. 58:296-301.
25. Nestler JE, Usiskin KS, Barlascini CO, Welty DF, Clore JN, Blackard WG. 1989 Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. J Clin Endocrinol Metab. 69:1040-1046.
26. Hatch R, Rosenfield RL, Kim MH, Tredway D. 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 140:815-830.
27. National Diabetes Data Group. 1979 Classification and diagnosis of diabetes mellitus and other diagnostic categories of glucose intolerance. Diabetes. 28: 1039-1057.
28. De Fronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-E223.
29. Bonora E, Moghetti P, Zancanaro C, et al. 1989 Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 68:374-378.
30. Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V. 1994 Isolated precocious pubarche: an approach. J Clin Endocrinol Metab. 79:582-589.
31. Ryan KJ, Smith OW. 1965 Biogenesis of steroid hormones in the human ovary. Recent Prog Horm Res. 21.367-409.
32. McAllister JM, Kerin JFP, Trant JM, et al. 1989 Regulation of cholesterol side-chain cleavage and 17α-hydroxylase/lyase activities in proliferating human theca interna cells in long term monolayer culture. Endocrinology. 125: 1959-1966.
33. Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI. 1483 Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase. J Clin Endocrinol Metab. 77:18-102.
34. Nesler JE, Kahwash Z. 1994 Sex-specific action of insulin increase the metabolic clearance rate of dehydroepiandrosterone in humans. J Clin Invest. 94: 1484-1489.
35. Nestler JE, McClanahan MA, Clore JN, Blackard WG. 1992 Insulin inhibits adrenal 17,20-lyase activity in man. J Clin Endocrinol Metab. 74:362-367.
36. O'Meara NM, Blackman JD, Ehrmann DA, et al 1993 Defects in β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1241-1247.
37. Conway GS, Clark PMS, Wong D. 1993 Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Clin Endocrinol (Oxf). 38:219-222.
38. Lucky AW, Rosenfield RL, McGuire J, Rudy S, Helke J. 1986 Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab. 62:840-848.
39. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 327:157-162.
40. Azziz R, Bradley EL, Potter HD, Boots LR. 1995 Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. J Clin Endocrinol Metab. 80:400-405.
41. Peiris AN, Aiman EJ, Drucker WD, Kissebah AH. 1989 The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women. J Clin Endocrinol Metab. 68:715-720.
42. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. 1994 Testosterone concentrations in women and men with NIDDM. Diabetes Care. 17: 405-411.
43. Simon D, Preziosi P, Barret-Connor E, et al. 1992 Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia. 35:173-177.
44. Haffner SM, Karhapaa P, Mykkanen L, Laakso M. 1994 Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 43:212-219.
45. Nestler JE, Barlascini CO, Clore JN, Blackard WG. 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat, but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 66:57-61.
46. Mortola JF, Yen SSC. 1990 The effects of oral dohydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:696-704.